ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0379

Clinical Evolution of Patients Diagnosed of Juvenile Idiopathic Arthritis After the Transitional Care Consultation

Alba Maria Torrat Noves1, Rebeca Perpiñan Perez2, Jose Ivorra Cortes1, Elena Grau Garcia1, Daniel Ramos Castro1, Pablo Francisco Muñoz Martínez3, Laura Mas Sanchez4, Carmen Riesco Barcena1, Anderson Victor Huaylla Quispe1, Samuel Leal Rodriguez1, Belen Villanueva Mañez1, Iago Alcantara Alvarez1, Isabel Martinez Cordellat1, Luis Gonzalez Puig1, Rosa Negueroles Albuixech1, Jose Eloy Oller Rodriguez1, Elvira Vicens Bernabeu1, Ernesto Tovar Sugrañes1, Marta De la Rubia Navarro4, Hikmat Charia1, Ines Canovas Olmos1, Carmen Najera Herranz1 and Jose Andres Roman Ivorra5, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Universidad Catolica de Valencia San Vicente Martir, Valencia, Spain, 3Rheumatology Department. HUP La Fe, Sagunto, Spain, 4Rheumatology Department. HUP La Fe, Valéncia, Spain, 5Hospital Universitari i Politècnic la Fe, Valencia, Spain

Meeting: ACR Convergence 2023

Keywords: Juvenile idiopathic arthritis, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0345–0379) Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile idiopathic arthritis (JIA) encompasses a group of chronic arthritis that begin in childhood. According to the International League of Associations for Rheumatology (ILAR) criteria, JIA can be divided into seven distinct groups: oligoarthritis, rheumatoid factor (RF) negative and positive polyarthritis, enthesitis related arthritis, psoriatic arthritis, systemic arthritis and undifferentiated arthritis.

Following their visit to the transitional consultation, these patients subsequently undergo clinical follow-up in adult rheumatology.

The objective of this study is to describe the evolution of clinical and analytical findings, as well as treatment data in patients with JIA after the transitional care consultation.

Methods: Descriptive, longitudinal, and retrospective study conducted on 70 patients diagnosed with JIA based on the ILAR criteria. These patients were followed-up in adult rheumatology consultations after being visited in the transitional consultation at a Spanish tertiary-level hospital. Data pertaining to clinical, laboratory, and treatment aspects were collected from both the adult and transitional consultations.

Results: 70 patients diagnosed of JIA (65.7% women) were included in the study, with a mean age at diagnosis of 9 years old and a mean age at the transitional consultation of 21 years. The average duration of follow-up after the initial diagnosis was 16 years, while the mean duration of follow-up after the transitional consultation was 4 years.

After the transitional consultation, 12.8% of the patients had a change in their diagnosis (table nº 1).

24 patients (34.3%), were lost to follow-up, primarily due to changes in the health department in the majority of cases.

Half of the patients with history of previous uveitis experienced new episodes following the transitional consultation. In contrast, a significant number of patients did not experience recurrences during their follow-up in adult rheumatology appointments (table n º 3). 100% of the patients who had new flares of uveitis after the transitional consultation had ANA+ in serum.

The frequency of oral and genital thrush, Raynaud phenomenon and diarrhea episodes decreased after the transitional consultation.

Out of the 28 patients who were in remission without treatment during the transitional care consultation, only 1 patient required initiation of therapy during their follow-up in adult rheumatology appointments.

Conclusion: 12.8% of the patients experienced a change in their diagnosis during their follow-up in the adult rheumatology consultation, with the majority of these cases being classified as undifferentiated JIA.

The majority of patients who were in remission without treatment during the transitional consultation did not require treatment during their follow-up in adult rheumatology appointments.

A significant number of patients experienced recurrences of uveitis after the transitional care consultation. However, new cases of uveitis in patients who had not previously experienced episodes were rare during the follow-up in adult rheumatology appointments.

Supporting image 1

Diagnosis changes

Supporting image 2

Cumulative incidence of clinical and analytical manifestations

Supporting image 3

Evolution of clinical and analytical manifestations


Disclosures: A. Torrat Noves: None; R. Perpiñan Perez: None; J. Ivorra Cortes: None; E. Grau Garcia: None; D. Ramos Castro: None; P. Muñoz Martínez: None; L. Mas Sanchez: None; C. Riesco Barcena: None; A. Huaylla Quispe: None; S. Leal Rodriguez: None; B. Villanueva Mañez: None; I. Alcantara Alvarez: None; I. Martinez Cordellat: None; L. Gonzalez Puig: None; R. Negueroles Albuixech: None; J. Oller Rodriguez: None; E. Vicens Bernabeu: None; E. Tovar Sugrañes: None; M. De la Rubia Navarro: None; H. Charia: None; I. Canovas Olmos: None; C. Najera Herranz: None; J. Roman Ivorra: None.

To cite this abstract in AMA style:

Torrat Noves A, Perpiñan Perez R, Ivorra Cortes J, Grau Garcia E, Ramos Castro D, Muñoz Martínez P, Mas Sanchez L, Riesco Barcena C, Huaylla Quispe A, Leal Rodriguez S, Villanueva Mañez B, Alcantara Alvarez I, Martinez Cordellat I, Gonzalez Puig L, Negueroles Albuixech R, Oller Rodriguez J, Vicens Bernabeu E, Tovar Sugrañes E, De la Rubia Navarro M, Charia H, Canovas Olmos I, Najera Herranz C, Roman Ivorra J. Clinical Evolution of Patients Diagnosed of Juvenile Idiopathic Arthritis After the Transitional Care Consultation [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/clinical-evolution-of-patients-diagnosed-of-juvenile-idiopathic-arthritis-after-the-transitional-care-consultation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-evolution-of-patients-diagnosed-of-juvenile-idiopathic-arthritis-after-the-transitional-care-consultation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology